Welcome to our dedicated page for Iqvia Hldgs news (Ticker: IQV), a resource for investors and traders seeking the latest updates and insights on Iqvia Hldgs stock.
IQVIA Holdings Inc. reports developments tied to its role as a global provider of clinical research services, commercial insights and healthcare intelligence for life sciences and healthcare customers. Company news commonly covers quarterly results for R&D Solutions and Commercial Solutions, contracted clinical-development activity, earnings guidance and management presentations at healthcare conferences.
Updates also include capital actions such as common-stock repurchase authorizations and technology announcements involving IQVIA Connected Intelligence™, Healthcare-grade AI® and IQVIA.ai, a unified agentic AI platform for clinical, commercial and real-world domains.
IQVIA Holdings reported third-quarter 2020 revenue of $2,786 million, a slight increase of 0.6% year-over-year, with Technology & Analytics Solutions (TAS) revenue growing 10.2%. However, Research & Development Solutions (R&DS) revenue fell 4.5%, and Contract Sales & Medical Solutions (CSMS) dropped 13.9%. Adjusted EBITDA reached $604 million, up 1.9%. The company raised its 2020 revenue guidance to $11,100 - $11,250 million and provided a strong outlook for 2021, anticipating revenue between $12,300 million and $12,600 million.
IQVIA (NYSE: IQV) announces a partnership with the U.S. FDA to analyze data from its CARE Project COVID-19 registry. This project aims to gather insights on COVID-19 symptoms experienced by U.S. residents, regardless of diagnosis. Launched in April 2020, over 20,000 participants have enrolled, providing data on symptom severity and potential effects of medications and supplements. Nancy Dreyer, Chief Scientific Officer, emphasizes the project's focus on community-level insights and the role of various preventive agents, leveraging IQVIA's CORE technology for rapid analytics.
IQVIA Holdings Inc. (NYSE: IQV) will release its third-quarter financial results on October 20, 2020, before the market opens. Management will host a conference call at 9:00 a.m. ET on the same day, which can be accessed via the IQVIA Investor Relations website. Registration is required for participation, and a replay will be available shortly after the event. IQVIA specializes in analytics and technology solutions for the life sciences sector, employing around 67,000 individuals globally.